Volume : 09, Issue : 05, May – 2022

Title:

35.APPLICATIONS OF HPTLC IN HERBAL DRUGS ANALYSIS

Authors :

Vidhyatai Jondhale*, Nikita Wagh, Shubhada Mohite, Dr. Milind Wagh, Monika Sonawane

Abstract :

The analysis and quality control of herbal medicines are going a step ahead towards an integrative and comprehensive direction, in order to equipment the complex nature of herbal medicines. High-performance thin layer chromatography (HPTLC) is one of the sophisticated instrumental techniques for quantitative and qualitative analysis of the herbs and herbal drugs. The reported HPTLC method was found to be rapid, simple, and accurate for substantiation of the herbal plant materials. Multidimensional chromatography is often a good choice in case of very multiplex samples, offering many advantageous features in the analysis of medicinal plants. First of all, multidimensional TLC is the only real multidimensional method in which, after the first separation in the first direction, all compounds can be passed to a second direction. A Quality Control for Authentication 107 fingerprint analysis methods to control the quality of herbal drugs have gradually come into being, such as GC, TLC, HPLC, etc. chromatographic fingerprint analysis of herbal drugs represents a comprehensive qualitative approach for the purpose of species authentication, evaluation of quality, and ensuring the consistency and stability of herbal drugs and their related products. For example, Ginseng and American ginseng, the HPTLC is difficult to distinguish them by only selecting single ginsenosides, but the HPTLC images with digital scanning profiles can easily be differentiated between them.
KEYWORDS: Herbal drugs, High-Performance Thin Layer Chromatography (HPTLC), Analytical methods

Cite This Article:

Please cite this article in press Vidhyatai Jondhale et al, Applications Of HPTLC In Herbal Drugs Analysis., Indo Am. J. P. Sci, 2022; 09(5).,

Number of Downloads : 10

References:

1) Sharma A., Shanker C., Tyagi L.K., Singh M., Rao V. Herbal Medicine for Market Potential in India: An Overview. Academic J. Plant Sci. 2008; 1 (2): 26-36.
2) Kadam P.V., Yadav K.N., Shivatare R.S., Pande A.S., Patel A.N., Patil M.J. Standardization of Gomutra Haritaki Vati: An Ayurvedic Formulation. Int. J. Pharm. Bio. Sci. 2012; 3(3): 181 – 187.
3) Mukharjee P.K., Wahile A. Integrated approaches towards drug development from Ayurveda and other Indian system of medicines. J. Ethanopharmacol. 2006; 103 (1): 25-35.
4) Choudhary N., Sekhon B.S. An overview of advances in the standardization of herbal drugs. J. Pharm. Educ. Res. 2011; 2 (2): 55-70.
5) Amit J., Sunil C., Vimal K., Anupam P. Phytosomes: A revolution in herbal drugs. The Pharma Review 2007; 11- 13.
6) Jena A., Saha D., Biswal B., Jana S.B., Koley A., Sur D., Battacharya A. Pharmacognostic Studies of leaves of Pterospermum Suberifolium. Int. J. Res. Pharmaceutical Biomed. Sci. 2011; 2(1): 2229-3701.
7) Bagul M.S., Rajani M. Phytochemical evaluation of classical formulation: A case study. Indian Drugs 2005; 42:15-19.
8) Jeganathan N.S., Kannan K. HPTLC Method for Estimation of Ellagic Acid and Gallic Acid in Triphalachurnam Formulations. Res. J. Phytochemistry 2008; 2 (1): 1-9.
9) Saraswathy A., Rukmani S., Ariyanathan S. Analysis of HinguvacadiCurna. Indian J. Trad. Knowledge 2009: 8(3):319-325.
10) Ahirwal B., Ahirwal D., Ram A. Evaluation of standards and quality control parameters of herbal drugs, Souvenir, recent trends in herbal therapy 2006: 25-29.
11) Wani M.S.. Herbal medicine and its standardization. Pharma info. 2007; 5(6): 1-6.
12) Ekka N.R., Namdeo K.P., Samal P.K. Standardization stratergies for herbal Drugs- an Overview. Res. J. Pharm. And Tech. 2008; 1(4):310-312.
13) Bele A.A., khale A. Standardisation of herbal drugs: an overview. Int. j. pharmacy 2011; 2(12): 56-60.
14) Sherma J. Review of HPTLC in drug analysis: 1996- 2009. J. AOAC Int. 2010; 93: 754-764.
15) US Pharmacopoeia National Formulary, USP 36/NF 31, United States Pharmacopoeial Convention. Inc., Rockville, MD, 2013.
16) Indian Pharmacopoeia, Volume-1, published by The Indian Pharmacopoeia Commission, Central Indian pharmacopoeia Laboratory Govt. Of India, Ministry of Health & Family Welfare Sector-23, Raj Nagar, Ghaziabad-201 00, 2007.
17) British Pharmacopeia (BP). Vol. II, Her Majesty‟s Stationary Office, London. 2001
18) Patra K.C., Pareta S.K., Harwansh R.K., Kumar J.K. Traditional approaches towards standardization of herbal medicines -A review. J. Pharm. Sci.Technol. 2010; 2 (11): 372- 379.
19) Folashade K.O., Omoregie E.H., Ochogu A.P. Standardization of herbal medicines – A review. Int. J. Biodiversity Conserv. 2012; 4(3): 101-112.
20) Attimarad M., Mueen Ahmed K.K., Aldhubaib B.E., Harsha S. High-performance thin layer chromatography: A powerful analytical technique in pharmaceutical drug discovery. Symposium HPTLC 2011: 2 (2)7: 1-75.
21) Reich E., Schibli A. Stationary Phases for Planar Separations – Plates for Modern TLC. LC GC 2005; 23: 58-69.
22) Shewiyo D.H., Kaaleb E., Rishab P.G., Dejaegherc B., Verbekec J.S., Heydenc Y.V. HPTLC methods to assay active ingredients in pharmaceutical formulations: A review of the method development and validation steps. J. Pharm. Biomedical Anal. 2012; 66: 11– 23.
23) Shuijun L., Gangyi L., Jingying J., Xiaochuan L., Chen Y. Liquid chromatography – negative ion electrospray tandem mass spectrometry method for the quantification of ezetimibe in human. Plasma J. Pharm. Biomed. Anal. 2006: 40(4): 987-992.
24) Patel R., Patel M., Dubey N., Dubey N., Patel B. HPTLC Method Development and Validation: Strategy to Minimize Methodological Failures. J. Food Drug Anal. 2012; 20(4): 794-804.
25) Sherma J. Modern thin layer chromatography. J. AOAC Int. 2008; 91: 1142-1144.
26) Ravali R., Phaneendra M., BhanuJyothi K., RamyaSanthoshi L., Sushma K. Recent Trends in Analytical Techniques for the Development of Pharmaceutical Drugs. J. Bioanal. Biomed. 2011: 1-7.
27) Renger B. Planar chromatographic procedures in pharmaceutical analysis. J. AOAC Int. 2001; 84: 1217.
28) Patel R.B., Patel M.R. An introduction to analytical method development for pharmaceutical formulations. Pharma Rev. 2008; 6 (4): 1-5.
29) Srivastava M.M. High-Performance Thin- Layer Chromatography (HPTLC).Springer Verlag Berlin Heidelberg 2011: 32-60.
30) Wagner H. Plant Drug Analysis: A Thin Layer Chromatography Atlas 2nd ed. Springer 1996. 30. Kalasz H., Bathori M. Pharmaceutical applications of TLC. LC–GC Eur 2001; 10: 311–321.
31) Sethi P.D. Quantitative Analysis of Pharmaceutical Formulations, High Performance Thin Layer Chromatography. CBS Publishers and Distributors, New Delhi, India, 1996: 1-30.
32) Gocan S. Stationary phases for thin-layer chromatography. J. Chromatogr. Sci. 2002; 40: 538–549.
33) Reich E and Schibli A (2008). High-Performance Thin-Layer Chromatography for the Analysis of Medicinal Plants, 1st edition, published by Thieme, New York.
34) Cies´la Ł and Waksmundzka-Hajnos M. Two-dimensional thin-layer chromatography in the analysis of secondary plant metabolites. J Chromatogr A, 2009b, 1216, 1035–1052.
35) Cies´la Ł and Waksmundzka-Hajnos M. A comparison of TLC methods for constructing medicinal plant fingerprints. Sep Sci 2009a; 6, 22–27.
36) Poole CF, Poole SK, Fernando WPN, Dean TA, Achmed HD and Berndt JA. Multidimensional and multimodal thin layer chromatography: pathway to the future. J Planar Chromatogr, 1989, 2, 336–345.
37) Giddings JC (1990). In Cortes HJ (ed.): Multidimensional Chromatography, 1st edition, published by Marcel Dekker, New York.
38) Nyiredy Sz (2001). Planar Chromatography – A Retrospective View for the Third Millennium, 1st edition, published by Springer, Budapest.
39) Reich E and Schibli A (2008). High-Performance Thin-Layer Chromatography for the Analysis of Medicinal Plants, 1st edition, published by Thieme, New York.
40) Poole CF and Poole SK. Multidimensionality in planar chromatography. J Chromatogr A, 1995, 703, 573–612.
41) World Health Organization (WHO), WPR/RC52/7: A Draft Regional Strategy for Traditional Medicine in Western Pacific. WHO Regional Committee, 52nd Session Darussalam, 10–14 Sept. 2001.
42) State Drug Administration of China, Technical requirements of the fingerprint in injection of Chinese Materia Medica. Chin Tradit Pat Med 2000; 22, 825.
43) Nyiredy S. Planar chromatographic method development using the PRISMA optimization system and flow charts. J. Chromatogr. Sci. 2002; 40: 553–563.
44) Koll K., Reich E., Blatter A., Veit M. Validation of standardized high-performance thin-layer chromatographic methods for quality control and stability testing of herbals. J. AOAC Int. 2003; 86: 909-915.
45) Sherma J. Review of HPTLC in drug analysis: 1996- 2009. J. AOAC Int. 2010; 93: 754-764.
46) MM Srivastava. Springer Verlag “High Performance Thin-Layer Chromatography (HPTLC), Berlin Heidelberg, 2011, 32-60.
47) H Wagner. Atlas “Plant Drug Analysis: A Thin Layer Chromatography”, 2nd ed., Springer, 1996.
48) Journal of Scientific and Innovative Research, 2013, 2(6), 1086-1096.
49) Xie PS. (2005a) The Chromatographic fingerprint of Chinese Herbal Medicine published by People’s Health Publishing House, Tianjin.